Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study.
Klemens FheodoroffAstrid ScheschonkaJörg WisselPublished in: Disability and rehabilitation (2020)
The ICF offers a broad framework for setting patient-centered, easily understandable goals for patients with spasticity, including goals related to (guided) self-management activities. This analysis sheds new light on patient needs and could direct future goal-driven botulinum toxin spasticity treatment focused on enabling patients to better manage activity limitations imposed by their body function impairments.Trial registration: NCT01603459 registered with ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/NCT01603459).Implications for RehabilitationThe ICF offers a broad framework for setting patient-centered, easily understandable goals for patients with spasticity.ICF domains that include general tasks and demands can be used to establish goals relating to (guided) self-management of spasticity.An ICF-based goal-setting framework may increase the comparability of clinical data across studies.
Keyphrases
- botulinum toxin
- spinal cord injury
- upper limb
- end stage renal disease
- global health
- newly diagnosed
- ejection fraction
- computed tomography
- chronic kidney disease
- cerebral palsy
- study protocol
- randomized controlled trial
- peritoneal dialysis
- electronic health record
- public health
- children with cerebral palsy
- big data
- working memory
- magnetic resonance
- data analysis
- artificial intelligence
- dual energy
- smoking cessation
- pet ct